Brought to you by 
Tripos in drug discovery collaboration with Arena
13 Jan 2000
Executive Summary
Tripos Inc. and Arena Pharmaceuticals will collaborate on the discovery of small molecule drugs that act as receptors. Tripos has taken an equity stake in Arena, and participated in the start-up's recent $17mm private financing.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Tripos in drug discovery collaboration with Arena
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice